Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.

Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Karen Dickinson, 57, was at an appointment about her knee when the osteopath noticed a mole on her lower back which tests ...

Researchers at Yale University have issued a message to Covid vaccine victims following a bombshell study published earlier ...